IP Library Granted Patent US 9,309,537
Granted Patent B2
US 9,309,537 · App. 13/513,100 · Granted Apr 12, 2016

Chimeric rat produced using rat embryonic stem cells in the presence of an ES cell differentiation suppressant

Inventors: Takahiro Ochiya (Tokyo, JP); Masaki Kawamata (Tokyo, JP)
Assignees: National Cancer Center; DS Pharma Biomedical Co., Ltd.
C12N15/873A01K67/0271A01K67/0276C12N9/22C12N15/8509A01K2217/00A01K2217/052A01K2227/105A01K2267/0393C07K2319/81C12N5/0606C12N15/85C12N2500/30C12N2501/065C12N2501/15C12N2501/998C12N2501/999
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,309,537
App. No.
13/513,100
Granted
Apr 12, 2016
Kind
B2
Abstract

The present invention provides a preparation method of a chimeric embryo and a chimeric rat, which is characterized by contacting a rat pluripotent stem cell and a host embryo in the presence of an ES cell differentiation inhibitor. The method includes (a) a step for contacting a fertilized host embryo collected from a female rat and a rat pluripotent stem cell in the presence of an ES cell differentiation suppressant, and (b) a step for culturing the host embryo in contact with the rat pluripotent stem cell to form a chimeric embryo.

Claims (14)

1. A method of preparing a chimeric embryo, comprising

(a) a step for introducing a rat pluripotent stem cell into a fertilized host embryo collected from a female rat, wherein the introducing is in a medium comprising an ES cell differentiation suppressant comprising an MEK inhibitor, a GSK3 inhibitor, and a TGFβ receptor inhibitor, to produce a chimeric rat embryo.

2. The method according to claim 1 , wherein the introducing is achieved by injecting the rat pluripotent stem cell into the host embryo.

3. The method according to claim 1 , wherein the rat pluripotent stem cell is introduced into the host embryo in a medium comprising the ES cell differentiation suppressant of step (a) and a ROCK inhibitor.

4. The method according to claim 1 , wherein the host embryo is precultured in a medium comprising the ES cell differentiation suppressant before introduction of the rat pluripotent stem cell.

5. The method according to claim 4 , wherein the preculture is performed in a medium comprising the ES cell differentiation suppressant and a ROCK inhibitor.

6. The method according to claim 2 , wherein the medium comprises the ES cell differentiation suppressant and a ROCK inhibitor.

7. The method according to claim 1 , wherein the pluripotent stem cell is an ES cell.

8. The method according to claim 1 , wherein the rat pluripotent stem cell is a pluripotent stem cell prepared from a rat of a strain that does not produce a germline-transmitted chimeric rat when introduced into a host embryo in the absence of the ES cell differentiation suppressant in the step (a).

9. The method according to claim 1 , wherein the host embryo is derived from a rat of a strain that does not produce a germline-transmitted chimeric rat when introduced with a rat pluripotent stem cell in the absence of the ES cell differentiation suppressant in the step (a).

10. The method according to claim 1 , further comprising (b) a step for culturing the chimeric embryo in a medium comprising the ES cell differentiation suppressant to form a chimeric blastocyst.

11. The method according to claim 10 , wherein the medium of step (b) comprises the ES cell differentiation suppressant and a ROCK inhibitor.

12. A method of preparing a chimeric rat, comprising transplanting a chimeric blastocyst prepared by the method according to claim 10 to the uterus or oviduct of a psuedopregnant female rat to allow an offspring rat to be born.

13. A method of preparing a rat with a contribution of a rat pluripotent stem cell to the whole body, comprising mating a chimeric rat obtained by the method according to claim 12 with a rat of the opposite sex.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2012
From: OCHIYA, TAKAHIRO; KAWAMATA, MASAKI
To: NATIONAL CANCER CENTER; DS PHARMA BIOMEDICAL CO., LTD.
Reel/Frame 028547/0942 →
Priority Claims (2)
JP 2009-274008 · Dec 1, 2009 · national
JP 2010-166571 · Jul 23, 2010 · national
Continuity (1)
Related Publication 20120272349A1 · Oct 25, 2012